Skip to main content
. 2020 Jul 6;39(11):2143–2152. doi: 10.1007/s10096-020-03946-0

Table 4.

Diagnostic odds ratios of all algorithms

Single-tier
DOR (95%-CI)
STTT
DOR (95%-CI)
MTTT-strict
DOR (95%-CI)
MTTT-permissive
DOR (95%-CI)
DOR with PopC sera
Enz1 30.9 (18.1–52.1) Enz1/RecomL 27.8 (12.5–61.6) Enz1/C6 68.4 (32.0–146.5) 69.5 (34.4–140.3)
Enz2 34.5 (20.3–58.4) Enz2/RecomL 27.8 (12.5–61.6) Enz2/C6 74.6 (34.8–160.1) 85.6 (41.0–178.6)
Lia 23.5 (13.8–40.0) Lia/RecomL 29.8 (12.7–69.9) Lia/C6 56.9 (26.6–121.3) 53.6 (27.3–104.9)
C6 51.3 (27.9–94.4) C6/RecomL 30.3 (12.9–71.2)
DOR with CRC sera
Enz1 7.3 (3.7–14.2) Enz1/RecomL 7.8 (2.9–20.4) Enz1/C6 15.1 (6.5–35.2) 14.3 (6.5–31.3)
Enz2 8.1 (4.2–15.9) Enz2/RecomL 7.8 (2.9–20.4) Enz2/C6 16.5 (7.0–38.5) 15.8 (7.2–34.6)
Lia 3.8 (2.0–7.3) Lia/RecomL 5.8 (2.4–14.2) Lia/C6 12.5 (5.4–29.2) 14.0 (6.2–31.6)
C6 21.6 (6.0–26.4) C6/RecomL 9.3 (3.2–26.7)

DOR, diagnostic odds ratio; 95%-CI, 95% confidence interval; STTT, standard two-tier testing; MTTT, modified two-tier testing; Enz1, Enzygnost-1; Enz2, Enzygnost-2; Lia, Liaison; C6, C6-ELISA; RecomL, RecomLine; EM, erythema migrans; PopC, population control; CRC, cross-reactive control; strict, counting equivocal EIA results as negative; permissive, counting equivocal EIA results as positive